Therapeutic Effect of Gamma Knife Radiosurgery for Multiple Brain Metastases.
10.3340/jkns.2011.50.3.179
- Author:
Chul Kyu LEE
1
;
Sang Ryul LEE
;
Jin Mo CHO
;
Kyung Ah YANG
;
Se Hyuk KIM
Author Information
1. Department of Neurosurgery, Gamma Knife Center, Ajou University School of Medicine, Suwon, Korea. nsksh@ajou.ac.kr
- Publication Type:Original Article
- Keywords:
Gamma knife radiosurgery;
Metastases;
Cerebral edema
- MeSH:
Brain Edema;
Brain*;
Breast;
Edema;
Follow-Up Studies;
Humans;
Lung;
Neoplasm Metastasis*;
Prescriptions;
Radiosurgery*;
Retrospective Studies;
Treatment Outcome;
Tumor Burden
- From:Journal of Korean Neurosurgical Society
2011;50(3):179-184
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: The aim of this study is to evaluate the therapeutic effects of gamma knife radiosurgery (GKRS) in patients with multiple brain metastases and to investigate prognostic factors related to treatment outcome. METHODS: We retrospectively reviewed clinico-radiological and dosimetric data of 36 patients with 4-14 brain metastases who underwent GKRS for 264 lesions between August 2008 and April 2011. The most common primary tumor site was the lung (n=22), followed by breast (n=7). At GKRS, the median Karnofsky performance scale score was 90 and the mean tumor volume was 1.2 cc (0.002-12.6). The mean prescription dose of 17.8 Gy was delivered to the mean 61.1% isodose line. Among 264 metastases, 175 lesions were assessed for treatment response by at least one imaging follow-up. RESULTS: The overall median survival after GKRS was 9.1+/-1.7 months. Among various factors, primary tumor control was a significant prognostic factor (11.1+/-1.3 months vs. 3.3+/-2.4 months, p=0.031). The calculated local tumor control rate at 6 and 9 months after GKRS were 87.9% and 84.2%, respectively. Paddick's conformity index (>0.75) was significantly related to local tumor control. The actuarial peritumoral edema reduction rate was 22.4% at 6 months. CONCLUSION: According to our results, GKRS can provide beneficial effect for the patients with multiple (4 or more) brain metastases, when systemic cancer is controlled. And, careful dosimetry is essential for local tumor control. Therefore, GKRS can be considered as one of the treatment modalities for multiple brain metastase.
